12 – 1 p.m. (ET) | 11a.m. –12 p.m. (CT) | 9 – 10 a.m. (PT)
intellectual property team for a webinar on strategic considerations for pharmaceutical and
medical device companies in litigating post grant proceedings before the
U.S. Patent and Trademark Office. Discussion will cover the interplay
between inter partes reviews and Hatch-Waxman cases, including proving or
rebutting secondary considerations, proving or rebutting that a reference
is a printed publication, and assessing issues regarding multiple
petitions, parallel proceedings, time bar and estoppel.
Our programs are intended for the benefit of our clients and contacts and we reserve the right to refuse any registration at our sole discretion.